With Tufts research showing average number of patient dropouts remains near 30%, and Advarra reporting that 35% of surveyed dropouts find consent forms “difficult to understand” it’s clear that there is still much to be done towards improving retention.
Join Medable and key patient advocates as we discuss common challenges faced by patients looking to participate in clinical trials.
We will explore how a patient-first approach to informed consent can improve patient education, engagement, and comprehension, ultimately improving retention.
Attendees will learn:
Vice President & General Manager, eConsent at Medable
Patient Advocate and CEO of Clinical Ambassador.
As a Senior Director of Solution Consultant, Camila Matheny leads value-driven presentations of all solutions offered by Medable.
Patient Advocate and Caregiver.